Number of oocytes retrieved · patients with endometriosis prior to standard IVF/ICSI
1 finding from 1 review
Mean number of embryos · patients with endometriosis prior to standard IVF/ICSI
1 finding from 1 review
Activities of daily living · older adults living in long‐term residential care including, but not limited to, dementia‐specific care settings
1 finding from 1 review
no estimate extracted
499 participants
Very low
ADL outcome · rehabilitation (long‐term outcomes)
1 finding from 1 review
Activity measures of the lower limb (lower limb activity) · rehabilitation (long‐term outcomes)
1 finding from 1 review
Motor impairment measures of the upper limb (upper limb impairment) · rehabilitation (long‐term outcomes)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Motor impairment measures of the lower limb (lower limb impairment) · rehabilitation (long‐term outcomes)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events/death: long‐term outcomes ‐ not reported · rehabilitation (long‐term outcomes)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Leaving the study early · people with both severe mental illness and substance misuse
RISPERIDONE showed no clear difference in leaving the study early: 1. any reason, long term (>12 months) compared with QUETIAPINE ‒ short‐ and long‐term data (low certainty).
1 finding from 1 review
No clinically important changes in specific symptoms ‐ positive and negative symptoms of schizophrenia (long term) Mental state: Not improved ‐ by 2 years ‐ as measured by PEF scale PEF scale · patients with people with severe mental illnesses
It is very uncertain whether SHORT changes no clinically important changes in specific symptoms ‐ positive and… compared with LONG HOSPITAL STAY (very low certainty).
1 finding from 1 review
Patient readmissions · patients with people with severe mental illnesses
SHORT showed no clear difference in service outcomes: 1a. Readmission to hospital (homogeneous studies)… compared with LONG HOSPITAL STAY (low certainty).
1 finding from 1 review
Leaving the study early · patients with people with severe mental illnesses
SHORT showed no clear difference in leaving the study early (long term) Participants leaving the study… compared with LONG HOSPITAL STAY (low certainty).
1 finding from 1 review
Clinician‐reported signs of eczema · people with eczema
1 finding from 1 review
Patient‐reported symptoms of eczema · people with eczema
1 finding from 1 review
Adverse effects: local · people with eczema
1 finding from 1 review
Systemic adverse events at · people with eczema
1 finding from 1 review
Change in quality of life · addition to tiotropium versus either tiotropium or LABA alone for chronic obstructive pulmonary disease
1 finding from 1 review
Quality of life SGRQ responder analysis at 6 months · addition to tiotropium versus either tiotropium or LABA alone for chronic obstructive pulmonary disease
Long‐acting beta2‐agonist plus tiotropium probably leads to higher quality of life SGRQ responder analysis at 6 months compared with tiotropium alone (moderate certainty).
1 finding from 1 review
Hospital admissions · addition to tiotropium versus either tiotropium or LABA alone for chronic obstructive pulmonary disease
Long‐acting beta2‐agonist plus tiotropium showed no clear difference in hospital admission (all cause) compared with tiotropium alone (moderate certainty).
1 finding from 1 review
Hospital admission (exacerbation) · addition to tiotropium versus either tiotropium or LABA alone for chronic obstructive pulmonary disease
Long‐acting beta2‐agonist plus tiotropium showed no clear difference in hospital admission (exacerbation) compared with tiotropium alone (low certainty).
1 finding from 1 review